20240025942. NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF simplified abstract (Sage Therapeutics, Inc.)

From WikiPatents
Jump to navigation Jump to search

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Organization Name

Sage Therapeutics, Inc.

Inventor(s)

Albert Jean Robichaud of Boston MA (US)

Francesco G. Salituro of Marlborough MA (US)

Boyd L. Harrison of Princeton Junction NJ (US)

Gabriel Martinez Botella of Wayland MA (US)

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240025942 titled 'NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Simplified Explanation

The abstract of this patent application describes a compound or a pharmaceutically acceptable salt thereof, which is envisioned to behave as a GABA modulator. The application also includes pharmaceutical compositions comprising the compound and methods of use and treatment, such as inducing sedation and/or anesthesia.

  • The compound described in the patent application is a GABA modulator.
  • The patent application includes pharmaceutical compositions containing the compound.
  • The compound can be used for inducing sedation and/or anesthesia.
  • The patent application provides methods of use and treatment involving the compound.
  • The compound may exist in the form of a pharmaceutically acceptable salt.

Potential applications of this technology:

  • Development of new sedatives and anesthetics.
  • Treatment of conditions requiring sedation or anesthesia.
  • Research and development of GABA modulators for various therapeutic purposes.

Problems solved by this technology:

  • Limited options for sedatives and anesthetics.
  • Need for more effective and safer sedation and anesthesia methods.
  • Lack of specific GABA modulators for therapeutic use.

Benefits of this technology:

  • Provides a new compound with GABA modulating properties.
  • Offers potential for improved sedation and anesthesia techniques.
  • Enables targeted modulation of GABA receptors for therapeutic purposes.


Original Abstract Submitted

or a pharmaceutically acceptable salt thereof; wherein r, r, rg, x, y, z, and n are as defined herein. such compounds are envisioned, in certain embodiments, to behave as gaba modulators. also provided are pharmaceutical compositions comprising a compound described herein and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.

Retrieved from "http://wikipatents.org/index.php?title=20240025942._NEUROACTIVE_STEROIDS,_COMPOSITIONS,_AND_USES_THEREOF_simplified_abstract_(Sage_Therapeutics,_Inc.)&oldid=29573"